US Patent 11103492 Compositions and kits for omeprazole suspension
Patent 11103492 was granted and assigned to Azurity Pharmaceuticals on August, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11103492 Compositions and kits for omeprazole suspension
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.